Evidence map›Paper›PMID 33647013›Full record

ArticlePLoS biology2021

Assessment of transparency indicators across the biomedical literature: How open is open?

Stylianos Serghiou, Despina G Contopoulos-Ioannidis, Kevin W Boyack, Nico Riedel, Joshua D Wallach, John P A Ioannidis

Abstract read
In one paragraph

Article in PLoS biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Prerequisite for reproducible science: a call to embrace code sharing.The Lancet regional health. Southeast Asia · 2024
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Stylianos SerghiouDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0002-2477-6060
Despina G Contopoulos-IoannidisDivision of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, United States of America.
Kevin W BoyackSciTech Strategies, Inc., Albuquerque, New Mexico, United States of America.
Nico RiedelBerlin Institute of Health, QUEST Center for Transforming Biomedical Research, Berlin, Germany.ORCID 0000-0002-3808-1163
Joshua D WallachDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut, United States of America.ORCID 0000-0002-2816-6905
John P A IoannidisDepartment of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California, United States of America.ORCID 0000-0003-3118-6859

Funding

Yale-Mayo FDA Center for Excellence in Regulatory Science and InnovationU01FD005938 · FDA · YALE UNIVERSITY · PI Joseph Solomon Ross · 2016 to 2026
$25.4M
FDA HHS U01 FD005938NIDA NIH HHS HHSN271201800033C
6 · The paper itself

Abstract

Recent concerns about the reproducibility of science have led to several calls for more open and transparent research practices and for the monitoring of potential improvements over time. However, with tens of thousands of new biomedical articles published per week, manually mapping and monitoring changes in transparency is unrealistic. We present an open-source, automated approach to identify 5 indicators of transparency (data sharing, code sharing, conflicts of interest disclosures, funding disclosures, and protocol registration) and apply it across the entire open access biomedical literature of 2.75 million articles on PubMed Central (PMC). Our results indicate remarkable improvements in some (e.g., conflict of interest [COI] disclosures and funding disclosures), but not other (e.g., protocol registration and code sharing) areas of transparency over time, and map transparency across fields of science, countries, journals, and publishers. This work has enabled the creation of a large, integrated, and openly available database to expedite further efforts to monitor, understand, and promote transparency and reproducibility in science.

Indexed as

Biomedical ResearchConflict of InterestDatabases, FactualDisclosureHumansInformation DisseminationOpen Access PublishingPublicationsReproducibility of ResultsScholarly Communication

Identifiers

PMID33647013
PMCPMC7951980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.